ES2177648T3 - Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana. - Google Patents

Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana.

Info

Publication number
ES2177648T3
ES2177648T3 ES95917797T ES95917797T ES2177648T3 ES 2177648 T3 ES2177648 T3 ES 2177648T3 ES 95917797 T ES95917797 T ES 95917797T ES 95917797 T ES95917797 T ES 95917797T ES 2177648 T3 ES2177648 T3 ES 2177648T3
Authority
ES
Spain
Prior art keywords
viruses
protection against
human immunodeficiency
against infection
synthetic vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95917797T
Other languages
English (en)
Inventor
Barton F Haynes
Thomas J Palker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Application granted granted Critical
Publication of ES2177648T3 publication Critical patent/ES2177648T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

INVENCION QUE SE REFIERE A PREPARACIONES INMUNOGENICAS DE PEPTIDOS QUE PEPTIDOS QUE INCLUYEN SECUENCIAS DE AMINOACIDOS QUE SE CORRESPONDEN CON DETERMINANTES ANTIGENICOS DE LA GLICOPROTEINA QUE ENVUELVE EL HIV, ACOPLADAS DE FORMA COVALENTE, DIRECTAMENTE O A TRAVES DE UNA MOLECULA ESPACIADORA, A MOLECULAS DE TRANSPORTE ADECUADAS PARA LA VACUNACION DE MAMIFEROS.
ES95917797T 1994-04-29 1995-04-28 Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana. Expired - Lifetime ES2177648T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23530594A 1994-04-29 1994-04-29

Publications (1)

Publication Number Publication Date
ES2177648T3 true ES2177648T3 (es) 2002-12-16

Family

ID=22884945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95917797T Expired - Lifetime ES2177648T3 (es) 1994-04-29 1995-04-28 Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana.

Country Status (10)

Country Link
EP (1) EP0762895B1 (es)
JP (1) JPH09512561A (es)
AT (1) ATE221786T1 (es)
AU (1) AU707894B2 (es)
CA (1) CA2189045A1 (es)
DE (1) DE69527708T2 (es)
DK (1) DK0762895T3 (es)
ES (1) ES2177648T3 (es)
PT (1) PT762895E (es)
WO (1) WO1995029700A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7465696A (en) * 1995-10-20 1997-05-07 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
NZ515322A (en) * 1999-05-13 2004-03-26 Wyeth Corp Adjuvant combination formulations
JP2004503205A (ja) 2000-02-04 2004-02-05 デューク・ユニバーシティー ヒト免疫不全ウイルスワクチン
JP2004511444A (ja) 2000-09-22 2004-04-15 デューク・ユニバーシティー 免疫原
US7033593B2 (en) 2000-09-22 2006-04-25 Duke University Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
WO2003039470A2 (en) 2001-11-07 2003-05-15 Duke University Polyvalent immunogen of hiv
US7195768B2 (en) 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7172761B2 (en) 2001-11-07 2007-02-06 Duke University Polyvalent immunogen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013548A (en) * 1987-09-08 1991-05-07 Duke University Production of antibodies to HIV
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV

Also Published As

Publication number Publication date
PT762895E (pt) 2002-11-29
WO1995029700A1 (en) 1995-11-09
DK0762895T3 (da) 2002-09-02
DE69527708D1 (de) 2002-09-12
AU2372695A (en) 1995-11-29
ATE221786T1 (de) 2002-08-15
EP0762895B1 (en) 2002-08-07
JPH09512561A (ja) 1997-12-16
AU707894B2 (en) 1999-07-22
DE69527708T2 (de) 2003-04-30
EP0762895A1 (en) 1997-03-19
EP0762895A4 (en) 1997-08-27
CA2189045A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
ES2177648T3 (es) Vacuna sintetica para proteccion frente a infeccion por virus de inmunodeficiencia humana.
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
AR020134A1 (es) Antigenos inmunologicos contra el virus herpes simplex y metodos para el uso de los mismos
CY1118521T1 (el) Συνθεση εμβολιου και μεθοδος χρησης αυτου
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
MX9700229A (es) Vacuna de polinucleotido para virus de papiloma.
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
MX303646A (es) Sistema portador contra la hormona de liberacion de gonadotropina.
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
ES2192559T3 (es) Vacuna para la proteccion de aves de corral contra la coccidiosis.
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
ATE193974T1 (de) Chlamydia impfstoffen
ES2058100T3 (es) Vacuna combinada.
NO924271L (no) Vaksiner med forbedret immunogenisitet
ES2159306T3 (es) Vacuna contra coccidiosis en pollos.
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
ES2077017T3 (es) Vacuna contra el virus de la bronquitis infecciosa.
ES2055610T3 (es) Vacuna contra hrsv.
PE20060860A1 (es) Vacuna basada en epitopes neutralizantes
AU4832097A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
CO4790102A1 (es) Vacuna contra la bursitis infecciosa
BR0013574A (pt) Antìgeno vacina de moraxella